Home / Bio-technology / Global and United States Renal Biomarkers Market

Global and United States Renal Biomarkers Market

  • Id : RNR-77443
  • Category : Bio-technology
  • Publish Date : Apr 2017
  • Pages : 137
  • Format : PDF
License Type

This report studies the Renal Biomarkers market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Renal Biomarkers market by product type and applications/end industries.

The global Renal Biomarkers market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. 

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Renal Biomarkers. United States plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of XX. 

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Renal Biomarkers in these regions, from 2012 to 2022 (forecast), covering
United States
North America
South America
Middle East and Africa

The major players in global and United States Renal Biomarkers market, including Astute Medical, BioMrieux, Abbott Diagnostics, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Siemens Healthcare Diagnostics Inc., Thermo Fisher Scientific Inc., Alere Inc., Randox Laboratories Ltd.,, 

The On the basis of product, the Renal Biomarkers market is primarily split into 
Blood urea nitrogen (BUN) 
Cystatin C
Neutrophil gelatinase-associated lipocalin (NGAL)

On the basis on the end users/applications, this report covers 
Diagnosis and disease progression monitoring